ST葫芦娃(605199.SH)及全资子公司获得药品注册证书

Group 1 - ST HuLuWa (605199.SH) announced the approval of drug registration certificates for Oseltamivir Phosphate Dry Suspension and Lactulose Oral Solution by the National Medical Products Administration [1] - Oseltamivir Phosphate Dry Suspension is indicated for the treatment of influenza A and B in adults and children aged 2 weeks and older, with a recommendation to use within 48 hours of symptom onset [1] - Lactulose Oral Solution is indicated for chronic functional constipation [1]